Indian stocks: Visit www.stage2stocks.com →

Surgery Partners, Inc.

Stage 4 · Declining · week 3

As of Oct 22, 2026, Surgery Partners is in Stage 4, the downtrend phase, now in week 3 (since Oct 5, 2026). It closed at $15.90, 30.7% below its 52-week high and above its 200-day average, which is falling.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. More about the company

$15.90
+3.25% today
$2.1B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is SGRY early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 20w
S4 35w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 6w → S4 11w → S1 12w → S4 20w → S1 7w → S2 9w → S3 4w → S4 10w → S1 8w → S4 11w → S1 3w → S4 4w → S1 4w → S4 35w → S1 9w → S2 5w → S3 3w → S4 3w current
Total tracked: 165 weeks across 19 stage runs.

SGRY among Medical Care Facilities37th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…37SGRYStage 4 · wk 337+9.2%
vs 52W High
-30.7%
$11.49 lo$22.94 hi
30.7% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 3
1w13w26w
Week 3, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
10.1%
200 DMA: $14.44 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.26x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+9.2%
3M
+1.1%
6M
+8.7%
YTD
+4.2%
1Y
-24.5%
Scan Membership
Breakout Watch
Latest: 2024-09-12
6 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 3 · Vol 1.26x
2026-10-21S4
Wk 3 · Vol 1.01x
2026-10-20S4
Wk 3 · Vol 1.89x
2026-10-19S4
Wk 3 · Vol 0.57x
2026-10-16S4
Wk 2 · Vol 0.42x
2026-10-15S4
Wk 2 · Vol 1.03x
2026-10-14S4
Wk 2 · Vol 0.62x
2026-10-13S4
Wk 2 · Vol 0.49x
2026-10-12S4
Wk 2 · Vol 0.53x
2026-10-09S4
Wk 1 · Vol 0.40x
2026-10-08S4
Wk 1 · Vol 0.56x
2026-10-07S4
Wk 1 · Vol 0.72x
Moving averages & range
50 DMA
$14.22
200 DMA
$14.44
52W High
$22.94
52W Low
$11.49
5D Low
$14.61
Resistance levels (recent highs)
20d High
$15.90
60d High
$16.06
120d High
$17.23
250d High
$22.94
Next resistance
+1.0%
to 60d High
ROE
+2.3%
Profit margin -2.6%
Dividend Yield
0.00%
P/B 1.2

Surgery Partners: quick answers

What stage is Surgery Partners in?

As of Oct 22, 2026, Surgery Partners (SGRY) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 5, 2026 and is in week 3. What the four stages mean

Is Surgery Partners in an uptrend?

No. Surgery Partners is in a Stage 4 downtrend. It trades 10.1% above its 200-day average, which is falling.

How far is Surgery Partners from its 52-week high?

Surgery Partners closed at $15.90 on Oct 22, 2026, 30.7% below its 52-week high of $22.94. Its 52-week low is $11.49.

How has Surgery Partners performed over the past year?

As of Oct 22, 2026, Surgery Partners is down 24.5% over the past year and up 4.2% so far in 2026.

Which sector and industry is Surgery Partners in?

Surgery Partners is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.